In vivo imaging of membrane type-1 matrix metalloproteinase with a novel activatable near-infrared fluorescence probe

Cancer Science

Volumn 105, Issue 8, 2014, Pages 1056-1062

  Shimizu, Yoichi ^a,b   Temma, Takashi ^a   Hara, Isao ^c   Makino, Akira ^a   Kondo, Naoya ^a   Ozeki, Ei ichi ^c   Ono, Masahiro ^a   Saji, Hideo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c SHIMADZU CORPORATION   (Japan)

Author keywords

Activatable probe; Membrane type 1 matrix metalloproteinase; Molecular imaging; Near infrared; Optical

Indexed keywords

CYANINE DYE; FLUORESCENT DYE; MATRIX METALLOPROTEINASE 14; MONOCLONAL ANTIBODY; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CELL MIGRATION; CONTROLLED STUDY; ENDOCYTOSIS; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VIVO STUDY; MCF 7 CELL LINE; METASTASIS; MICELLE; MOUSE; NEAR INFRARED FLUORESCENCE IMAGING; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION;

ACTIVATABLE PROBE; MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE; MOLECULAR IMAGING; NEAR-INFRARED; OPTICAL;

ANIMALS; FLUORESCENCE; HETEROGRAFTS; MATRIX METALLOPROTEINASE 14; MICE; NEOPLASMS; OPTICAL IMAGING; RATS; SPECTROSCOPY, NEAR-INFRARED;

EID: 84906940038     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12457     Document Type: Article

References (35)

1. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
2. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25: 9-34.
3. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
4. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-5.
5. Chen PS, Zhai WR, Zhou XM et al. Effects of hypoxia, hyperoxia on the regulation of expression and activity of matrix metalloproteinase-2 in hepatic stellate cells. World J Gastroenterol 2001; 7: 647-51.
6. Uekita T, Itoh Y, Yana I, Ohno H, Seiki M. Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 2001; 155: 1345-56.
7. D'Alessio S, Ferrari G, Cinnante K et al. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J Biol Chem 2008; 283: 87-99.
8. Li J, Zucker S, Pulkoski-Gross A et al. Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking. PLoS ONE 2012; 7: e38403.
9. Yang CC, Zhu LF, Xu XH, Ning TY, Ye JH, Liu LK. Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. BMC Cancer 2013; 13: 171.
10. Shimizu Y, Temma T, Sano K, Ono M, Saji H. Development of membrane type-1 matrix metalloproteinase-specific activatable fluorescent probe for malignant tumor detection. Cancer Sci 2011; 102: 1897-903.
11. Shimizu Y, Temma T, Hara I et al. Development of novel nanocarrier-based near-infrared optical probes for in vivo tumor imaging. J Fluoresc 2012; 22: 719-27.
12. Shimizu Y, Temma T, Hara I et al. Micelle-based activatable probe for in vivo near-infrared optical imaging of cancer biomolecules. Nanomedicine 2014; 10: 187-95.
13. Kondo N, Temma T, Shimizu Y et al. Miniaturized antibodies for imaging membrane type-1 matrix metalloproteinase in cancers. Cancer Sci 2013; 104: 495-501.
14. Temma T, Sano K, Kuge Y et al. Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors. Biol Pharm Bull 2009; 32: 1272-7.
15. Lafleur MA, Mercuri FA, Ruangpanit N, Seiki M, Sato H, Thompson EW. Type I collagen abrogates the clathrin-mediated internalization of membrane type 1 matrix metalloproteinase (MT1-MMP) via the MT1-MMP hemopexin domain. J Biol Chem 2006; 281: 6826-40.
16. Galvez BG, Matias-Roman S, Yanez-Mo M, Vicente-Manzanares M, Sanchez-Madrid F, Arroyo AG. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell 2004; 15: 678-87.
17. Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K. Long-circulating poly(ethylene glycol)-poly(D, L-lactide) block copolymer micelles with modulated surface charge. J Control Release 2001; 77: 27-38.
18. Xiao K, Li Y, Luo J et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 2011; 32: 3435-46.
19. Bertin A. Emergence of polymer stereocomplexes for biomedical applications. Macromol Chem Phys 2012; 213: 2329-52.
20. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387-92.
21. Senior JH. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst 1987; 3: 123-93.
22. Derfus AM, Chan CWC, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004; 4: 11-8.
23. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996; 17: 93-102.
24. Tsai G, Lane HY, Yang P, Chong MY, Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 2004; 55: 452-6.
25. Murphy CJ, Gole AM, Stone JW et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 2008; 41: 1721-30.
26. Kobayashi H, Ogawa M, Alford R, Choyke PL, Urano Y. New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev 2010; 110: 2620-40.
27. Luo S, Zhang E, Su Y, Cheng T, Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials 2011; 32: 7127-38.
28. Zhao T, Harada H, Teramura Y et al. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells. J Control Release 2010; 144: 109-14.
29. Myochin T, Hanaoka K, Komatsu T, Terai T, Nagano T. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene. J Am Chem Soc 2012; 134: 13730-7.
30. Williams KC, Coppolino MG. Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration. J Biol Chem 2011; 286: 43405-16.
31. McCann TE, Kosaka N, Choyke PL, Kobayashi H. The use of fluorescent proteins for developing cancer-specific target imaging probes. Methods Mol Biol 2012; 872: 191-204.
32. Licha K. Contrast agents for optical imaging. Top Curr Chem 2002; 222: 1-29.
33. Tromberg BJ, Cerussi A, Shah N et al. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res 2005; 7: 279-85.
34. Polom K, Murawa D, Rho YS, Nowaczyk P, Hunerbein M, Murawa P. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer 2011; 117: 4812-22.
35. Gioux S, Choi HS, Frangioni JV. Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 2010; 9: 237-55.